"Immunoaffinity Chromatography with Affinity Supports", Bio-Rad Bulletin 1099, (1990). |
H. Lilja et al., "Prostate Specific Antigen Predominantly Forms a Complex with Alpha.sub.1 -Antichymotrypsin in Blood", Cancer Supplement, 70 (1992), pp. 230-234. |
K. Pettersson et al, "Development of Immunoflourometric Methods for PSA to Improve the Discrimination Between Early Prostate Cancer and Benign Prostatic Hyperplasia" XV International Congress of Clinical Chemistry (1993). |
O. Nilsson et al., "Epitope mapping of PSA, and development of asays for the determination of different isoforms of PSA", CanAg Diagnostics AB, (1993). |
"Epitope mapping of PSA, and development of asays for the determination of different isoforms of PSA", Abstract P38, Journal Tumor Marker Oncology, (1993) 10th Int'l Conference on Human Tumor Markers. |
Pharmacia LKB Biotechnology, Affinity Chromatography principles & methods. |
W. G. Wood et al., "The Establishment and Evaluation of Luminescent-Labelled Immunometric Assays for Prostate-Specific Antigen-.alpha..sub.1`-Antichymotrypsin Complexes in Serum", European Journal Clinical Chemistry Clinical Biochemistry, 29(1991), pp. 787-794. |
Pharmacia LKB Biotechnology, "Coupling gels for ligand immobilization", Affinity Chromatography principales & methods, (1993) pp. 23-30. |
A. Christensson et al., "Serum Prostate Specific Antigen Complexed to .alpha.1-Antichymotrypsin as an indicator or Prostate Cancer", Journal of Urology, 150(1993), pp. 100-105. |
U. Stenman et al., "A Complex between Prostate-specific Antigen and .alpha.1-Antichymotrypsin Is the Major Form of Prostate-specific Antigen in Serium of Patients with Prostatic Cancer: Assay of the Complex Improves Clinical Sensitivity for Cancer" Cancer Research, 51(1991) pp. 222-226. |
H. Lilja et al., "Prostate-Specific Antigen in Serum Occurs Predominantly in Complex with .alpha.1-Antichymotrypsin", Clinical Chemistry, 37,(1991) pp. 1618-1625. |
B. Bluestein et al., "Multi-Site Clinical Evaluation of an Automated Chemiluminescent Immunoassay for Prostate Specific Antigen (ACS.TM.PSA)", Journal of Tumor Marker Oncology, 7(1992), pp. 41-60. |
K. Watt et al., "Human prostate-specific antigen: Structural and functional similarity with serine proteases", Proc. Natl. Acad. Sci. USA, 83(1986), pp. 3166-3170. |
Y. Ban et al., "The Proteolytic Activity of Human Prostate-Specific Antigen", Biochemical and Biophysical Research Communications, 123 (1984), pp. 482-490. |
T. A. Stamey et al., "Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate", The New England Journal of Medicine, 317 (1987), pp. 909-916. |
M. Kurlyama et al., "Multiple Marker Evaluation in Human Prostate Cancer with the use of Tissue-specific Antigens", J. Nat'l Cancer Inst., 68 (1982), pp. 99-105. |
P. H. Lange et al., "Serum Prostate-Specific Antigen: its use in Diagnosis and Management of Prostate Cancer" Supplement to Urology, 33 (Jun. 1989) pp. 13-17. |
M. K. Brawer et al., "Prostate-Specific Antigen in Management of Prostatic Carcinoma", Supplement to Urology, 33(May 1989) pp. 11-16. |
P. H. Lange et al., "The Value of Serum Prostate Specific Antigen Determinations Before and After Radical Prostatectomy", Journal of Urology, 141(1989), pp. 873-879. |
T. A. Stamey et al., "Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate.II. Radical Prostatectomy Treated Patients", The Journal of Urology, 141 (1989), pp. 1076-1083. |
J. E. Oesterling et al., "Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy", The Journal of Urology, 139(1988), pp. 766-772. |
W. H. Scouten, "Affinity Chromatography for protein isolation", Current Opinion in Biotechnology, 2 (1991), pp. 37-43. |
M. Flore, "The Abbott IMx.TM. Automated Benchtop Immunochemistry Analyzer System", Clinical Chemistry, 34 (1988), pp. 1726-1732. |
M. J. Duffy, "New cancer Markers", Ann Clin Biochem, 26 (1989), pp. 379-387. |
A. Lundwall, "Characterization of the gene for Prostate-specific antigen, a human glandular kallikrein", Biochemical and Biophysical Research Communicatications, 161(1989), pp. 1151-1159. |
M. Kuriyama, "Quantitation of Prostate-specific Antigen in Serum by a Sensitive Enzyme Immunoassay", Cancer Research, 40 (1980) pp. 4658-4662. |
D. W. Chan, "Prostate-Specific Antigen as a Marker for Prostatic Cancer: a Monoclonal and a Polyclonal Immunoassay Compared", Clinical Chemistry, 33 (1987) pp. 1916-1920. |
C. S. Killian, "Prognostic Importance of Prostate-specific Antigen for Monitoring Patients with States B.sub.2 to D.sub.1 Prostate Cancer", Cancer Research, 45(1985) pp. 886-891. |
C. Schneider, "A One-step Purification of Membrane Proteins Using a High Efficiency Immunomatrix", The Journal of Biological Chemistry, 257(1982), pp. 10766-10769. |
A. Johnstone, "Affinity chromatography and immunoprecipitation", Immunochemistry in Practice, Scientific Publications, Oxford, 1st Edition (1982) pp. 202-232. |
T. H. Ji, "Bifunctional Reagents", Methods in Enzymology, 91(1983), p. 580. |
SS. Wong, "Protein Chemical Cross-Linking", Biocatalyst Design for Stability and Specificity, Chp. 22, pp. 266-282. |
A. Barnes, "The Abbott IMx.RTM. and IMx Select.TM. Systems", Journal Clin. Immunoasssay, 2 (1991), pp. 115-119. |
M. C. Wang, "Purification of a Human Prostate Specific Antigen", Investigative Urology 17, pp. 159-163. |
J. K. Siddall, "An Evaluation of the Immunochemical Measurement of Prostatic Acid Phosphatase and Prostatic Specific Antigen in Carcinoma of the Prostate", Euro, Urol., 12(1986), pp. 123-130. |
T. A. Stamey, "Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. IV. Anti-Androgen Treated Patients", The Journal of Urology, 141(1989), pp. 1088-1090. |
T. A. Stamey, "Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. III. Radiation Treated Patients", The Journal of Urology, `141(1989), pp. 1084-1087. |
R. L. Lundblad, Chemical Reagents for Protein Modification, 2nd Edition, CRC Press, 1991. |
M. N. Gupta, "Cross-Linking Techniques", Biocatalyst Design for Stability and Specificity, pp. 308-326. |
M. M. Manson, ed., "Immunochemical Protocols" Methods in Molecular Biology, 10(1992), pp. 89-91. |